Page last updated: 2024-09-04
docetaxel anhydrous and trofosfamide
docetaxel anhydrous has been researched along with trofosfamide in 1 studies
Compound Research Comparison
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (trofosfamide) | Trials (trofosfamide) | Recent Studies (post-2010) (trofosfamide) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 120 | 23 | 13 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Andritzky, B; Anige, M; Bokemeyer, C; Brandl, S; Burkholder, I; Edler, L; Görn, M; Habermann, CR; Hossfeld, DK; Laack, E; Schuch, G; Thöm, I | 1 |
Trials
1 trial(s) available for docetaxel anhydrous and trofosfamide
Article | Year |
---|---|
A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC).
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Humans; Lung Neoplasms; Middle Aged; Pilot Projects; Practice Patterns, Physicians'; Survival Analysis; Survival Rate; Taxoids; Treatment Outcome | 2008 |